News
Cataract Awareness Month highlights global efforts to prevent blindness through advancements in surgical care and lens replacement.
10d
GlobalData on MSNGlaukos gains EU certification for iStent infinite and other MIGS devicesThe iStent infinite Trabecular Micro-Bypass System Model iS3 is for minimising IOP in those with primary open-angle glaucoma.
Both 6-month trials were randomized, controlled studies that evaluated PER-001 delivered in a slow-release, dissolvable ...
When I’m talking to patients with glaucoma, my goal is to gradually build on their understanding of the disease so they are armed with the information they need to help preserve their vision over the ...
Kevin Choi uses AI to detect critical diseases early through retinal scans. He said AI helps in screening, but it won't ...
Interventional glaucoma refers to the mindset that in first-line treatment for this condition, we consider procedural ...
Top Cleveland Clinic and University of Iowa eye doctors explain it's not just blurry vision or irritation—and not just any ...
Causes of glaucoma are many and varied. Sometimes genetics are the culprit. Other times it can be an underlying illness such as diabetes, high blood pressure, heart or thyroid disease. Stress, eye ...
Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...
Glaukos has claimed a series of regulatory clearances in Europe for its micro-scale surgical implants to treat patients with ...
New technologies and a proactive mindset are transforming how glaucoma is diagnosed and treated—and redefining what ...
DOI: 10.1093/pnasnexus/pgaf168 Gene editing could be used to treat millions of glaucoma patients. Glaucoma is a leading cause of blindness, characterized by high pressure inside the eye.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results